Inhibition of calpain blocks pancreatic β-cell spreading and insulin secretion

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 2 52-2, 2005, Pages

  Parnaud, Géraldine ^a   Hammar, Eva ^a   Rouiller, Dominique G ^a   Bosco, Domenico ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Extracellular matrix; Intracellular calcium

Indexed keywords

ALOXISTATIN; CALCIUM ION; CALPAIN; CALPASTATIN; CALPEPTIN; CYSTEINE PROTEINASE; GLUCOSE; MASTOPARAN; N ACETYLLEUCYLLEUCYLNORLEUCINAL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ADHESION; CELL MIGRATION; CELL VACUOLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; EXOCYTOSIS; EXTRACELLULAR MATRIX; INSULIN RELEASE; INSULIN SYNTHESIS; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; CALCIUM; CALPAIN; CELL MOVEMENT; CELL PROLIFERATION; CELL SIZE; CELLS, CULTURED; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; INSULIN; INTRACELLULAR FLUID; ISLETS OF LANGERHANS; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 23044502665     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00006.2005     Document Type: Article

References (44)

1. Amin RH, Chen HQ, Veluthakal R, Silver RB, Li J, Li G, and Kowluru A. Mastoparan-induced insulin secretion from insulin-secreting betaTC3 and INS-1 cells: evidence for its regulation by Rho subfamily of G proteins. Endocrinology 144: 4508-4518, 2003.
2. Bosco D, Gonelle-Gispert C, Wollheim CB, Halban PA, and Rouiller DG. Increased intracellular calcium is required for spreading of rat islet β-cells on extracellular matrix. Diabetes 50: 1039-1046, 2001.
3. Bosco D, Meda P, Halban PA, and Rouiller DG. Importance of cell-matrix interactions in rat islet beta-cell secretion in vitro: role of alpha6beta1 integrin. Diabetes 49: 233-243, 2000.
4. Carragher NO, Levkau B, Ross R, and Raines EW. Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol 147: 619-630, 1999.
5. Chen M and Fernandez HL. Stimulation of beta-amyloid precursor protein alpha-processing by phorbol ester involves calcium and calpain activation. Biochem Biophys Res Commun 316: 332-340, 2004.
6. Croce K, Flaumenhaft R, Rivers M, Furie B, Furie BC, Herman IM, and Potter DA. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 274: 36321-36327, 1999.
7. Dourdin N, Bhatt AK, Dutt P, Greer PA, Arthur JS, Elce JS, and Huttenlocher A. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J Biol Chem 276: 48382-48388, 2001.
8. Forsythe P and Befus AD. Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J Immunol 170: 287-293, 2003.
9. Fox JE. On the role of calpain and Rho proteins in regulating integrin-induced signaling. Thromb Haemost 82: 385-391, 1999.
10. Glading A, Lauffenburger DA, and Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12: 46-54, 2002.
11. Glading A, Uberall F, Keyse SM, Lauffenburger DA, and Wells A. Membrane proximal ERK signaling is required for M-calpain activation downstream of epidermal growth factor receptor signaling. J Biol Chem 276: 23341-23348, 2001.
12. Goll DE, Thompson VF, Li H, Wei W, and Cong J. The calpain system. Physiol Rev 83: 731-801, 2003.
13. Hellman B, Berne C, Grapengiesser E, Grill V, Gylfe E, and Lund PE. The cytoplasmic Ca2+ response to glucose as an indicator of impairment of the pancreatic beta-cell function. Eur J Clin Invest 20, Suppl 1: S10-S17, 1990.
14. Hood JL, Logan BB, Sinai AP, Brooks WH, and Roszman TL. Association of the calpain/calpastatin network with subcellular organelles. Biochem Biophys Res Commun 310: 1200-1212, 2003.
15. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PE, del Bosque-Plata L, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, and Bell GI. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 26: 163-175, 2000.
16. Huang Y and Wang KK. The calpain family and human disease. Trends Mol Med 7: 355-362, 2001.
17. Jones PM and Persaud SJ. Protein kinases, protein phosphorylation, and the regulation of insulin secretion from pancreatic beta-cells. Endocr Rev 19: 429-461, 1998.
18. Kantengwa S, Baetens D, Sadoul K, Buck CA, Halban PA, and Rouiller DG. Identification and characterization of alpha 3 beta 1 integrin on primary and transformed rat islet cells. Exp Cell Res 237: 394-402, 1997.
19. Kitahara A, Ohtsuki H, Kirihata Y, Yamagata Y, Takano E, Kannagi R, and Murachi T. Selective localization of calpain 1 (the low-Ca2+-requiring form of Ca2+-dependent cysteine proteinase) in B-cells of human pancreatic islets. FEBS Lett 184: 120-124, 1985.
20. Komatsu M, McDermott AM, Gillison SL, and Sharp GW. Mastoparan stimulates exocytosis at a Ca(2+)-independent late site in stimulus-secretion coupling. Studies with the RINm5F beta-cell line. J Biol Chem 268: 23297-23306, 1993.
21. Kulkarni S, Goll DE, and Fox JE. Calpain cleaves RhoA generating a dominant-negative form that inhibits integrin-induced actin filament assembly and cell spreading. J Biol Chem 277: 24435-24441, 2002.
22. Kulkarni S, Saido TC, Suzuki K, and Fox JE. Calpain mediates integrin-induced signaling at a point upstream of Rho family members. J Biol Chem 274: 21265-21275, 1999.
23. Marshall C, Hitman GA, Partridge CJ, Clark A, Ma H, Shearer TR, and Turner MD. Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic beta-cells. Mol Endocrinol 19:. 213-224, 2005.
24. Martin KH, Slack JK, Boerner SA, Martin CC, and Parsons JT. Integrin connections map: to infinity and beyond. Science 296: 1652-1653, 2002.
25. Molinari M and Carafoli E. Calpain: a cytosolic proteinase active at the membranes. J Membr Biol 156: 1-8, 1997.
26. Nixon RA. The calpains in aging and aging-related diseases. Ageing Res Rev 2: 407-418, 2003.
27. Ort T, Voronov S, Guo J, Zawalich K, Froehner SC, Zawalich W, and Solimena M. Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 20: 4013-4023, 2001.
28. Perrin BJ and Huttenlocher A. Calpain. Int J Biochem Cell Biol 34: 722-725, 2002.
29. Pfaff M, Du X, and Ginsberg MH. Calpain cleavage of integrin beta cytoplasmic domains. FEBS Lett 460: 17-22, 1999.
30. Potter DA, Tirnauer JS, Janssen R, Croall DE, Hughes GN, Fiacco KA, Mier JW, Maki M, and Herman IM. Calpain regulates actin remodeling during cell spreading. J Cell Biol 141: 647-662, 1998.
31. Ray SK, Hogan EL, and Banik NL. Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors: Brain Res Brain Res Rev 42: 169-185, 2003.
32. Riddelle KS, Green KJ, and Jones JC. Formation of hemidesmosomes in vitro by a transformed rat bladder cell line. J Cell Biol 112: 159-168, 1991.
33. Rock MT, Dix AR, Brooks WH, and Roszman TL. Beta1 integrin-mediated T cell adhesion and cell spreading are regulated by calpain. Exp Cell Res 261: 260-270, 2000.
34. Rosser BG, Powers SP, and Gores GJ. Calpain activity increases in hepatocytes following addition of ATP. Demonstration by a novel fluorescent approach. J Biol Chem 268: 23593-23600, 1993.
35. Rouiller DG, Cirulli V, and Halban PA. Differences in aggregation properties and levels of the neural cell adhesion molecule (NCAM) between islet cell types. Exp Cell Res 191: 305-312, 1990.
36. Sasaki T, Kishi M, Saito M, Tanaka T, Higuchi N, Kominami E, Katunuma N, and Murachi T. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins. J Enzyme Inhib 3: 195-201, 1990.
37. Schoenwaelder SM, Yuan Y, and Jackson SP. Calpain regulation of integrin alpha Ub beta 3 signaling in human platelets. Platelets 11: 189-198, 2000.
38. Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, Lee JP, Ostrega DM, Pugh W, Horikawa Y, Cox NJ, Hanis CL, Burant CF, Fox AP, Bell GI, and Polonsky KS. Calpains play a role in insulin secretion and action. Diabetes 50: 2013-2020, 2001.
39. Sutton R, Peters M, McShane P, Gray DW, and Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42: 689-691, 1986.
40. Vainzof M, de Paula F, Tsanaclis AM, and Zatz M. The effect of calpain 3 deficiency on the pattern of muscle degeneration in the earliest stages of LGMD2A. J Clin Pathol 56: 624-626, 2003.
41. Van De Winkel M, Smets G, Gepts W, and Pipeleers D. Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells. J Clin Invest 70: 41-49, 1982.
42. Weber H, Hopp HH, Wagner AC, Noack T, Jonas L, Luthen F, and Schliff-Werner P. Expression and regulation of calpain in rat pancreatic acinar cells. Pancreas 24: 63-74, 2002.
43. Zhou YP, Sreenan S, Pan CY, Currie KP, Bindokas VP, Horikawa Y, Lee JP, Ostrega D, Ahmed N, Baldwin AC, Cox NJ, Fox AP, Miller RJ, Bell GI, and Polonsky KS. A 48-hour exposure of pancreatic islets to calpain inhibitors impairs mitochondrial fuel metabolism and the exocytosis of insulin. Metabolism 52: 528-534, 2003.
44. Zimmerman UJ, Wang M, and Liu L. Inhibition of secretion from isolated rat alveolar epithelial type II cells by the cell permeant calpain inhibitor 11 (N-acetyl-leucyl-leucyl-methioninal). Cell Calcium 18: 1-8, 1995.